Quarterly ResultAug 13, 2026, 11:34 AM
Adia Nutrition Q2 Revenue +310.8% to $485K; Net Income $40K
AI Summary
Adia Nutrition reported a significant increase in revenue for the second quarter of 2026, reaching $485,385, up 310.8% year-over-year, and achieved a net income of $40,418 compared to a loss in the prior year. For the six months ended June 30, 2026, revenue grew to $661,660, and the net loss was reduced. Despite these improvements, the company has an accumulated deficit of over $16 million and management expressed substantial doubt about its ability to continue as a going concern.
Key Highlights
- Q2 2026 revenue increased by 310.8% to $485,385 from $118,146 in Q2 2025.
- Q2 2026 net income was $40,418, a significant improvement from a net loss of $123,997 in Q2 2025.
- Six months ended June 30, 2026, revenue grew 248.4% to $661,660 from $189,910 in the prior year.
- Six months ended June 30, 2026, net loss reduced to $122,107 from $240,216 in the prior year.
- The company reported an accumulated deficit of $16,095,589 as of June 30, 2026.
- Cash balance at June 30, 2026, was $128,115, up from $79,392 at December 31, 2025.
- Management noted substantial doubt about the company's ability to continue as a going concern.
- Primary focus is on facilitating Autologous Hematopoietic Stem Cell Transplantation (AHSCT) treatments for MS patients.
Price Impact
More from ADIA